trial · primary record
ONC206
Advanced Pheochromocytoma and Paraganglioma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 90 |
| Primary completion | 2028-12-15 |
| Primary endpoint | Overall Response Rate (ORR) by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 |
| Registry ID | NCT07282587 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:06.056Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07282587
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.